Toronto, Ontario–(Newsfile Corp. – July 6, 2021) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce the company has received the results from the 14-day oral toxicity preclinical study conducted by KGK Science, a licensed CRO in Canada.


Previous articleCybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence
Next articlePT252 – Joel Lambert – Ibogaine, 5-MeO-DMT, and The Warrior Tradition